Quality of life and primary sclerosing cholangitis: The business of defining what counts-Reference-Cited by-同舟云学术

Quality of life and primary sclerosing cholangitis: The business of defining what counts

Published:2018-05-02 Issue:1 Volume:68 Page:16-18
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Arndtz Katherine¹²³,Hirschfield Gideon M.¹²³

Affiliation:

1. National Institute for Health Research Birmingham Biomedical Research Centre; Birmingham UK

2. Institute of Immunology & Immunotherapy; University of Birmingham; Birmingham UK

3. Centre for Rare Diseases, Institute of Translational Medicine, Birmingham Health Partners; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital; Birmingham UK

Funder

National Institute for Health Research Birmingham Liver Biomedical Research Centre

National Institute for Health Research

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29775/fullpdf

Reference6 articles.

1. Primary sclerosing cholangitis;Hirschfield;Lancet,2013

2. Primary sclerosing cholangitis and the management of uncertainty and complexity;Arndtz;Frontline Gastroenterol,2017

3. Factors that influence health-related quality of life in patients with primary sclerosing cholangitis;Cheung;Dig Dis Sci,2016

5. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process;Ponsioen;Hepatology,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support (Q.RARE.LI): study protocol for a transnational effectiveness-implementation hybrid trial;BMC Psychiatry;2023-03-24

2. PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis;BMC Gastroenterology;2023-03-15

4. Health-related quality of life and symptoms in autoimmune liver diseases;Minerva Gastroenterology;2023-02

5. Quality of life (QoL) for people with primary sclerosing cholangitis (PSC): a pragmatic strategy for identifying relevant QoL issues for rare disease;Journal of Patient-Reported Outcomes;2022-07-15